33 results
8-K
EX-1.1
SCTL
Societal CDMO Inc
13 May 21
Entry into a Material Definitive Agreement
4:41pm
Disclosure Package”), as of the Applicable Time, did not include any untrue statement of a material fact or omit to state any material fact necessary … Writing Prospectus, as supplemented by and taken together with the Pricing Disclosure Package as of the Applicable Time, did not include any untrue
8-K
EX-1.1
SCTL
Societal CDMO Inc
13 Dec 22
Entry into a Material Definitive Agreement
5:27pm
(collectively, the “Pricing Disclosure Package”), as of the Applicable Time, did not include any untrue statement of a material fact or omit to state any … and each such Issuer Free Writing Prospectus, as supplemented by and taken together with the Pricing Disclosure Package as of the Applicable Time, did
8-K
EX-1.2
SCTL
Societal CDMO Inc
13 Dec 22
Entry into a Material Definitive Agreement
5:27pm
in Schedule II(c) hereto and each General Use Issuer Free Writing Prospectus, taken together (collectively, the “Pricing Disclosure Package … , as supplemented by and taken together with the Pricing Disclosure Package as of the Applicable Time, did not include any untrue statement of a material fact
8-K
SCTL
Societal CDMO Inc
18 Apr 19
Entry into a Material Definitive Agreement
6:05am
the Company holds the New Drug Application (“NDA”), to Watson and Watson has an exclusive license to package, import, use, offer for sale and sell
S-1/A
EX-10.15
SCTL
Societal CDMO Inc
29 Nov 13
IPO registration (amended)
12:00am
in Office
Mail and package receipt and handling
Storage facilities
Twenty-four-hour a day, seven-day a week office access
Ample free parking
8-K
EX-99.1
fxzr06i
11 May 21
Other Events
4:33pm
8-K
EX-99.1
bjgestc
1 Jun 21
Regulation FD Disclosure
8:52am
8-K
EX-99.2
0m19hq
6 May 21
Recro Reports First Quarter 2021 Financial Results
4:46pm
8-K
EX-99.2
jer950njr
1 Oct 18
Recro Announces Expansion of CDMO Service Capabilities
12:00am
8-K
EX-99.1
xxe1i4jqtskoknw2 x1d
7 Jan 19
Other Events
7:01am
8-K
EX-99.2
am9m4
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.2
u5fv779c nokl
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
yq53lvzn37zv6wi8ai
10 May 18
Results of Operations and Financial Condition
7:03am
8-K
EX-99.1
ut6rqssdad 1cz5a
12 Nov 21
Regulation FD Disclosure
7:09am
8-K
EX-99.2
bqcjvjc
1 Mar 22
Recro Reports Fourth Quarter and Year End 2021 Financial Results
4:12pm
8-K
EX-99.2
06dkidr87
11 May 22
Societal CDMO Reports First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
sb35jo7xq7264 sv9dxg
23 Aug 21
CorporatePresentation August 2021
9:21am
8-K/A
EX-10.1
xribiearedhtkp8g4w
6 Mar 19
Entry into a Material Definitive Agreement
5:02pm